8VC

Even is a health tech company that collaborates with leading hospitals to provide comprehensive healthcare services through a subscription model. Its offerings include unlimited diagnostics, consultations, and hospitalization coverage valued at up to 50 lakh. The company simplifies the reimbursement process by directly transferring funds to partner hospitals, ensuring a seamless experience for members. By charging a recurring monthly fee, Even aims to address critical long-term health needs for individuals, making healthcare more accessible and manageable.

Candid Health is a platform that automates revenue cycle management for healthcare providers, facilitating efficient tracking of claims and management of billing processes. Utilizing machine learning and artificial intelligence, the platform streamlines medical billing, coding, and claims processing, thereby reducing administrative burdens and enhancing operational efficiency. By offering end-to-end automation, Candid Health optimizes financial operations for clinics and hospitals, allowing healthcare providers to concentrate on delivering quality, affordable, and accessible care while ensuring faster service reimbursement. The platform seamlessly integrates with existing systems, providing modern tools that simplify the complexities of medical billing and improve overall patient experiences.

Even is a health tech company that collaborates with leading hospitals to provide comprehensive healthcare services through a subscription model. Its offerings include unlimited diagnostics, consultations, and hospitalization coverage valued at up to 50 lakh. The company simplifies the reimbursement process by directly transferring funds to partner hospitals, ensuring a seamless experience for members. By charging a recurring monthly fee, Even aims to address critical long-term health needs for individuals, making healthcare more accessible and manageable.

Operator of a data-driven healthcare startup intended to transform healthcare in rural communities through exceptional care, bringing better access and quality service to its patients. The company delivers tailored quality care through a team-based model, with resources and support for patients, inside and outside clinics, thereby enabling healthcare professionals to provide the support and care that patients need.

Luminate Medical is focused on developing a medical device aimed at preventing hair loss during chemotherapy. Recognizing the significance of hair for personal identity and self-esteem, the company has created a portable and comfortable wearable system. This innovative device allows patients to manage and mitigate the side effects associated with cancer treatment, thereby helping them maintain their confidence and dignity during a challenging time. By leveraging advances in medical technology, Luminate Medical is dedicated to enhancing the quality of life for individuals undergoing chemotherapy.

Oula Health, Inc. specializes in maternity care services, offering both in-clinic and home-based prenatal care. Founded in 2019 and located in Brooklyn, New York, Oula aims to transform the maternity care experience by integrating obstetrics and midwifery. The company focuses on providing a personalized and evidence-based approach to pregnancy, combining modern medical practices with a compassionate understanding of human needs. Through its innovative maternity center, Oula sets a new standard for pregnancy care that emphasizes both medical expertise and personal connection.

Vital Bio is focused on transforming lab testing to make healthcare more accessible and personalized. The company develops advanced diagnostic technologies that connect diagnosis and treatment through a comprehensive ecosystem of devices, software, and services. By empowering patients to monitor their health and manage diseases, Vital Bio aims to enhance the overall healthcare experience. Their approach seeks to reduce disparities in healthcare outcomes and redistribute control to patients while equipping healthcare providers with the tools necessary to achieve better results.

Oula Health, Inc. specializes in maternity care services, offering both in-clinic and home-based prenatal care. Founded in 2019 and located in Brooklyn, New York, Oula aims to transform the maternity care experience by integrating obstetrics and midwifery. The company focuses on providing a personalized and evidence-based approach to pregnancy, combining modern medical practices with a compassionate understanding of human needs. Through its innovative maternity center, Oula sets a new standard for pregnancy care that emphasizes both medical expertise and personal connection.

Our mission is to redefine the standard of care in pulmonary medicine and deliver the best lung care in America. We’re rebuilding the pulmonary clinic around a technology platform and a set of virtual and physical interventions calibrated to keep lung conditions under control. At a Nimbus Clinic, rich patient data and predictive models allow our providers to make more thoughtful medical decisions, and step in at exactly the right moment.

Digital Diagnostics Inc. is an artificial intelligence diagnostics company focused on enhancing healthcare through technology. Founded in 2010 by Michael Abramoff, MD, PhD, the company has developed a suite of autonomous algorithms that analyze medical images to detect various diseases. Its flagship products include IDx-DR, which identifies diabetic retinopathy; IDx-G, which monitors glaucoma indicators; and IDx-AMD, designed to detect age-related macular degeneration. The company also offers algorithms for diagnosing conditions such as Alzheimer's disease, cardiovascular disease, and stroke risk. By providing these innovative solutions, Digital Diagnostics aims to improve the quality, accessibility, equity, and affordability of healthcare worldwide. Operating from Coralville, Iowa, the company distributes its products both domestically and internationally, striving to integrate autonomous AI into standard clinical practices and enhance patient outcomes.

Candid Health is a platform that automates revenue cycle management for healthcare providers, facilitating efficient tracking of claims and management of billing processes. Utilizing machine learning and artificial intelligence, the platform streamlines medical billing, coding, and claims processing, thereby reducing administrative burdens and enhancing operational efficiency. By offering end-to-end automation, Candid Health optimizes financial operations for clinics and hospitals, allowing healthcare providers to concentrate on delivering quality, affordable, and accessible care while ensuring faster service reimbursement. The platform seamlessly integrates with existing systems, providing modern tools that simplify the complexities of medical billing and improve overall patient experiences.

Cellino is focused on creating an automated biomanufacturing system for personalized cell therapies, with the aim of making these treatments widely accessible. The company leverages an AI-guided laser editing platform that employs image-guided machine learning and robotics to generate autologous induced pluripotent stem cells (iPSCs) at scale. This innovative approach is designed to facilitate the development of potentially curative therapies for chronic degenerative diseases, such as vision loss and Parkinson's disease. By streamlining the process of cell therapy production, Cellino aims to enhance the availability of life-saving medicines for patients around the world.

Ritten operates an electronic medical records platform designed specifically for addiction treatment providers to enhance the quality of care for their patients. The platform facilitates personalized, data-informed care by offering customized workflow configurations that support the consistent and compliant delivery of complex treatment. It enables clinicians and administrators to maintain comprehensive patient records that encompass all aspects of a patient's care, including clinical notes, medications, and treatment plans. This approach allows healthcare professionals to provide tailored care while effectively tracking patient progress and needs.

Pair Team focuses on enhancing primary care infrastructure for vulnerable communities, particularly those served by safety-net systems, Medicaid, and Medicare patients. As a tech-enabled care team, it extends the capabilities of clinical staff by offering personalized, high-touch care experiences. The organization addresses various barriers to healthcare, including transportation issues, housing and food insecurity, and limited mobile access. Pair Team employs a dedicated care team consisting of community health workers, registered nurses, and behavioral health clinicians to deliver comprehensive support tailored to the needs of low-income individuals. Additionally, the company is developing a care delivery platform designed to implement clinical best practices, integrate services with community-based organizations, and streamline administrative tasks, allowing clinicians to dedicate more time to patient care.

Better Health is a support and supplies platform designed to improve the management of chronic conditions such as ostomy, chronic wounds, diabetes, chronic retention, and incontinence through peer-to-peer connections. The platform offers expert guidance to help patients select and use the appropriate medical supplies while providing education and support to enhance engagement and adherence to treatment. This approach is endorsed by healthcare payers and providers, leading to better health outcomes, reduced overutilization of services, and improved mental health for users. Better Health operates across 48 states and collaborates with major payers, including Medicare, Medicaid, and several private insurers. The platform boasts a high customer satisfaction rating of 98%, reflecting its effectiveness in modernizing the medical supplies industry and lowering healthcare costs for insurers and patients alike.

Examedi is a healthcare startup that facilitates at-home medical services by connecting patients with independent nurses and lab technicians. Through its telemedicine platform, Examedi allows patients to book diagnostic tests and examinations, including blood tests, pregnancy tests, general checkups, and COVID tests. This service prioritizes accessibility and affordability, ensuring that patients can receive necessary medical care in the comfort of their homes. By coordinating the schedules of healthcare providers with patient needs, Examedi aims to enhance the convenience and efficiency of healthcare delivery.

Maximus is a consumer telemedicine company for men’s health and hormone optimization. Maximus is revolutionizing the performance enhancement space by democratizing doctor-prescribed protocols developed by some of the world’s leading experts in men’s health. Maximus’ King Protocol utilizes a convenient prescription medication capsule to stimulate natural testosterone production, proven by at-home lab tests. Maximus was established in 2020 by Cameron Sepah in Santa Monica, California.

Cityblock Health, established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a communication and task management tool called Commons. Cityblock's model focuses on prevention-oriented care and collaboration with community-based organizations to deliver personalized care to low-income urban residents. During the COVID-19 pandemic, the company developed a risk assessment model to identify high-risk members within its network.

Better Health is a support and supplies platform designed to improve the management of chronic conditions such as ostomy, chronic wounds, diabetes, chronic retention, and incontinence through peer-to-peer connections. The platform offers expert guidance to help patients select and use the appropriate medical supplies while providing education and support to enhance engagement and adherence to treatment. This approach is endorsed by healthcare payers and providers, leading to better health outcomes, reduced overutilization of services, and improved mental health for users. Better Health operates across 48 states and collaborates with major payers, including Medicare, Medicaid, and several private insurers. The platform boasts a high customer satisfaction rating of 98%, reflecting its effectiveness in modernizing the medical supplies industry and lowering healthcare costs for insurers and patients alike.

Cellino is focused on creating an automated biomanufacturing system for personalized cell therapies, with the aim of making these treatments widely accessible. The company leverages an AI-guided laser editing platform that employs image-guided machine learning and robotics to generate autologous induced pluripotent stem cells (iPSCs) at scale. This innovative approach is designed to facilitate the development of potentially curative therapies for chronic degenerative diseases, such as vision loss and Parkinson's disease. By streamlining the process of cell therapy production, Cellino aims to enhance the availability of life-saving medicines for patients around the world.

SummerBio LLC is an automation-based diagnostics company focused on providing COVID-19 testing services. Established in 2020 and based in Menlo Park, California, the company operates a CLIA-certified laboratory that utilizes a comprehensive, automated COVID-19 testing system. This system is designed to enhance the efficiency of the gold-standard RT-qPCR testing regimen by using advanced robotics, automated liquid handling, and innovative sample collection kits. By streamlining the testing process, SummerBio aims to deliver rapid, affordable, and high-volume testing solutions, ensuring that healthcare professionals and patients receive test results within a day.

Avail Medsystems, Inc. is a digital healthcare company that develops a platform designed to remotely connect healthcare experts with practitioners. The company's integrated audio/visual hardware and software system facilitates procedural support, observation, and clinical education services, allowing healthcare professionals to collaborate effectively. By enabling real-time access to clinical expertise, Avail aims to eliminate physical, economic, and logistical barriers in the healthcare industry. This approach promotes innovation and enhances the adoption of medical tools and techniques, ultimately improving patient care. Founded in 2017 and based in Palo Alto, California, Avail Medsystems was previously known as Nurep, Inc. and underwent a name change in March 2018.

Cityblock Health, established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a communication and task management tool called Commons. Cityblock's model focuses on prevention-oriented care and collaboration with community-based organizations to deliver personalized care to low-income urban residents. During the COVID-19 pandemic, the company developed a risk assessment model to identify high-risk members within its network.

Candid Health is a platform that automates revenue cycle management for healthcare providers, facilitating efficient tracking of claims and management of billing processes. Utilizing machine learning and artificial intelligence, the platform streamlines medical billing, coding, and claims processing, thereby reducing administrative burdens and enhancing operational efficiency. By offering end-to-end automation, Candid Health optimizes financial operations for clinics and hospitals, allowing healthcare providers to concentrate on delivering quality, affordable, and accessible care while ensuring faster service reimbursement. The platform seamlessly integrates with existing systems, providing modern tools that simplify the complexities of medical billing and improve overall patient experiences.

Nines is a pioneering teleradiology practice that focuses on enhancing patient care through advanced technology. The company develops in-house tools that empower radiologists to provide high-quality diagnostics. Its platform is designed to analyze medical scans for urgent findings that necessitate immediate attention, as well as to identify subtle details that assist in the radiological review process. This innovative approach aims to improve the accuracy of results and overall patient care, setting Nines apart in the field of radiology.

Cityblock Health, established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a communication and task management tool called Commons. Cityblock's model focuses on prevention-oriented care and collaboration with community-based organizations to deliver personalized care to low-income urban residents. During the COVID-19 pandemic, the company developed a risk assessment model to identify high-risk members within its network.

Digital Diagnostics Inc. is an artificial intelligence diagnostics company focused on enhancing healthcare through technology. Founded in 2010 by Michael Abramoff, MD, PhD, the company has developed a suite of autonomous algorithms that analyze medical images to detect various diseases. Its flagship products include IDx-DR, which identifies diabetic retinopathy; IDx-G, which monitors glaucoma indicators; and IDx-AMD, designed to detect age-related macular degeneration. The company also offers algorithms for diagnosing conditions such as Alzheimer's disease, cardiovascular disease, and stroke risk. By providing these innovative solutions, Digital Diagnostics aims to improve the quality, accessibility, equity, and affordability of healthcare worldwide. Operating from Coralville, Iowa, the company distributes its products both domestically and internationally, striving to integrate autonomous AI into standard clinical practices and enhance patient outcomes.

uBiome, Inc. was a microbial genomics company based in San Francisco, California, founded in 2012. It specialized in sequencing-based clinical microbiome tests, offering products such as SmartGut, a test for identifying pathogenic and commensal microorganisms related to infections, and SmartJane, a women's health screening test that detects various conditions including HPV and STIs. The company also provided Explorer kits for citizen scientists and researchers, as well as SmartFlu, a clinical respiratory test. By leveraging precision sequencing combined with machine learning and artificial intelligence, uBiome aimed to enhance the understanding of the human microbiome, enabling healthcare providers to deliver more accurate diagnoses and empowering patients to manage their health more effectively. However, uBiome faced financial difficulties and filed for Chapter 11 bankruptcy in September 2019, which was later converted to Chapter 7 on October 11, 2019.

Mammoth Biosciences, Inc. is a biotechnology company based in South San Francisco, California, that focuses on developing innovative CRISPR solutions for a variety of applications. The company offers DETECTR™, a diagnostic platform that identifies specific nucleic acids in samples, aiding in the detection of diseases such as bacterial infections, cancer, and viral infections. Additionally, Mammoth Biosciences provides CRISPR-Cas systems for genome editing, targeting therapeutic areas including immuno-oncology, autoimmune diseases, and liver diseases. By harnessing proprietary ultracompact proteins and leveraging advanced research and development, Mammoth aims to create affordable point-of-care tests and enhance diagnostics across healthcare, agriculture, and environmental monitoring. Co-founded by CRISPR pioneer Jennifer Doudna, the company has attracted significant investment from institutional and individual backers.

Opencare Inc. operates a healthcare discovery platform that connects patients with healthcare providers in North America, primarily focusing on dental services. Founded in 2012 and based in Toronto, Canada, the company's platform allows users to find and book appointments online with a variety of healthcare professionals, including dentists, chiropractors, massage therapists, physiotherapists, and optometrists. By transforming the dental industry, Opencare aims to provide patients with confidence in receiving high-quality care while also facilitating practice growth for top dentists. The platform streamlines interactions between patients and providers, ensuring a convenient and rewarding experience for all users. Opencare was previously known as HealthKiwi Inc. before rebranding in March 2018.

Notable is an AI-driven platform designed to enhance healthcare operations and improve physician-patient interactions. Deployed at over 10,000 care sites, it automates more than a million repetitive workflows daily, including processes related to registration, scheduling, authorizations, and chart reviews. The platform features a voice-powered application that organizes physician-patient conversations and dictations while securely recommending appropriate billing codes. By streamlining these tasks, Notable reduces manual workload for caregivers and fosters personalized care for patients, ultimately contributing to better financial health for healthcare providers.

100Plus is a rapidly growing remote patient monitoring platform designed to enhance the care of elderly patients with chronic conditions. The platform provides comprehensive services, including patient outreach, device setup, patient engagement, and automatic billing, all integrated with medical devices. By enabling doctors to monitor high-risk seniors remotely, 100Plus helps to prevent costly episodic care and promotes a higher quality of life for patients. When a Medicare patient receives a 100Plus medical device, it is delivered at no cost to them or their healthcare providers, fully configured and ready for immediate use, eliminating the need for smartphones, apps, Bluetooth, or WiFi.

Coral Genomics, Inc. is a biotechnology company based in San Francisco, California, founded in 2018. The company specializes in optimizing drug development and deployment through the use of genomic data derived from patients. Coral Genomics focuses on creating new clinical tests that assist healthcare providers in streamlining prior authorization processes and selecting effective medications tailored to individual patients, particularly those with autoimmune conditions such as Inflammatory Bowel Disease and Rheumatoid Arthritis. Additionally, the company has identified a distinct population of non-responder patients and collaborates with drug developers to address their unmet medical needs.

Mammoth Biosciences, Inc. is a biotechnology company based in South San Francisco, California, that focuses on developing innovative CRISPR solutions for a variety of applications. The company offers DETECTR™, a diagnostic platform that identifies specific nucleic acids in samples, aiding in the detection of diseases such as bacterial infections, cancer, and viral infections. Additionally, Mammoth Biosciences provides CRISPR-Cas systems for genome editing, targeting therapeutic areas including immuno-oncology, autoimmune diseases, and liver diseases. By harnessing proprietary ultracompact proteins and leveraging advanced research and development, Mammoth aims to create affordable point-of-care tests and enhance diagnostics across healthcare, agriculture, and environmental monitoring. Co-founded by CRISPR pioneer Jennifer Doudna, the company has attracted significant investment from institutional and individual backers.

uBiome, Inc. was a microbial genomics company based in San Francisco, California, founded in 2012. It specialized in sequencing-based clinical microbiome tests, offering products such as SmartGut, a test for identifying pathogenic and commensal microorganisms related to infections, and SmartJane, a women's health screening test that detects various conditions including HPV and STIs. The company also provided Explorer kits for citizen scientists and researchers, as well as SmartFlu, a clinical respiratory test. By leveraging precision sequencing combined with machine learning and artificial intelligence, uBiome aimed to enhance the understanding of the human microbiome, enabling healthcare providers to deliver more accurate diagnoses and empowering patients to manage their health more effectively. However, uBiome faced financial difficulties and filed for Chapter 11 bankruptcy in September 2019, which was later converted to Chapter 7 on October 11, 2019.

RondinX, founded in 2015 by prominent microbiome experts, focuses on developing innovative solutions in the microbiome therapeutic and companion diagnostic sectors. The company offers a drug discovery platform that utilizes its proprietary Peak-to-Trough (PTR) family of algorithms. This cloud-based computational pipeline generates both static and dynamic insights into bacterial ecosystems at the strain level, facilitating advanced target and drug discovery. Through its specialized approach, RondinX aims to enhance the understanding and treatment of microbiome-related health issues.